Results 141 to 150 of about 4,299,415 (353)

Spinal Cord Abnormalities in Early Pediatric Multiple Sclerosis

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Spinal cord lesions and atrophy in the cervical region are common in adult multiple sclerosis (MS) and correlate with disability. Whether similar abnormalities occur in pediatric MS patients is largely unknown. Clinical and MRI evaluations were performed in 38 pediatric MS patients and 13 healthy controls (HC).
Monica Margoni   +7 more
wiley   +1 more source

Obesity and the Heart: Webcast March 18 2025

open access: yesMethodist DeBakey Cardiovascular Journal
This 76-minute webcast features a conversation about “Obesity and the Heart”—the focus of Issue 21.2. Led by the issue’s editor, the discussion engages the authors on emerging themes and lessons learned while researching and writing the articles.
Miguel Quiñones   +8 more
doaj   +1 more source

NMDAR‐Antibody Encephalitis Diagnosed With Primary Central Nervous System Lymphoma: A Case Series

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT N‐methyl‐D‐aspartate receptor‐antibody encephalitis (NMDAR encephalitis) is one of the most common forms of autoimmune encephalitis, with a paraneoplastic relationship described in approximately 38%. Primary central nervous system lymphoma (PCNSL) is a rare hematologic malignancy that is not often considered as the underlying neoplasm in this ...
Soo Hyun Ahn   +4 more
wiley   +1 more source

Breeding for Egg Shell Quality as Indicated by Egg Weight Loss

open access: hybrid, 1945
Joseph P. Quinn   +2 more
openalex   +1 more source

Escapable-inescapable shock and body weight loss [PDF]

open access: bronze, 1968
Donald M. Ragusa   +2 more
openalex   +1 more source

The MSA Atrophy Index (MSA‐AI): An Imaging Marker for Diagnosis and Clinical Progression in Multiple System Atrophy

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Reliable biomarkers are essential for tracking disease progression and advancing treatments for multiple system atrophy (MSA). In this study, we propose the MSA Atrophy Index (MSA‐AI), a novel composite volumetric measure to distinguish MSA from related disorders and monitor disease progression. Methods Seventeen participants with an
Paula Trujillo   +11 more
wiley   +1 more source

Home - About - Disclaimer - Privacy